TIRZEPATIDE — ONE MONTH SUPPORT
Tirzepatide is a GIP and GLP-1 receptor agonist used as part of an individualized weight-management plan. It can help reduce appetite and food intake and support weight reduction when used alongside appropriate nutrition and physical activity.
ONE MONTH SUPPORT
This option is designed for clients who prefer a one-month support option rather than attending weekly in-person appointments.
FIRST-TIME CLIENTS
A consultation is required before getting started. During your consultation, we will discuss:
• Your current weight and weight-loss goals
• Relevant health history
• Current medications
• Previous GLP-1 or weight-management treatment
• Any questions or concerns
This helps determine the appropriate next step and whether additional medical clearance may be required.
IMPORTANT INFORMATION
Tirzepatide may not be appropriate for everyone. You must disclose if you are pregnant or breastfeeding, trying to become pregnant, taking another GLP-1 medication, or have relevant medical conditions or medications.
Tirzepatide has important contraindications and warnings, including a personal or family history of medullary thyroid carcinoma (MTC), MEN 2, and serious hypersensitivity to tirzepatide.
Possible side effects include nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion and other gastrointestinal symptoms.
Individual results vary. Weight-loss results are not guaranteed. Treatment should follow an appropriate individualized plan under qualified medical supervision.
QUESTIONS BEFORE GETTING STARTED?
Call or WhatsApp 876-588-1926
Conditions apply.
